Arkstone Announces RightDose, a Groundbreaking Enhancement to Ensure Proper Antimicrobial Prescribing
This innovative feature addresses the complexities healthcare providers face when dosing for different age groups and accommodating reduced renal and hepatic function
Arkstone, the leader in laboratory infectious disease guidance and proactive antimicrobial stewardship, is thrilled to announce a groundbreaking enhancement to its OneChoice platform: RightDose™. This innovative feature addresses the complexities of dosing across all age groups, with a special focus on the unique challenges of pediatric care, by providing tailored dosage recommendations for neonates, infants, children, and adolescents.Treating pediatric patients requires a nuanced approach, as different age groups necessitate precise dosages of antibiotics. However, gathering this data is a complex task, as there is currently no single source for pediatric dosing available anywhere. Healthcare providers often have to research this information on their own, leading to inefficiencies and potential errors in prescribing. With Arkstone's RightDose feature, healthcare providers no longer need to search for this critical information, streamlining the prescribing process and reducing the risk of errors.RightDose extends beyond pediatric care, offering comprehensive dosing data for patients of all ages, ensuring that healthcare providers have access to precise information tailored to each patient's unique needs. This feature also includes adjustments for renal and hepatic function, enhancing patient safety and accuracy in prescribing antibiotics.Arkstone's drug database, the most comprehensive of its kind, centralizes dosing information from multiple sources, enabling detailed recommendations for patients from neonates to adults. There is no other single source of antibiotic dosing data available, making Arkstone an indispensable resource for healthcare providers seeking precise, evidence-based guidance.Dr. Ari Frenkel, Chief Science Officer at Arkstone, expressed his excitement for the impact of this new feature, stating, "The inclusion of RightDose in our OneChoice platform represents a significant milestone in our commitment to advancing precision-guided medicine. By providing detailed dosage instructions tailored to the specific age bracket of each pediatric patient—and accommodating for factors like renal and hepatic function—we're equipping healthcare providers with the tools they need to deliver optimal, personalized care."Dave Gross, Chief Technology Officer at Arkstone, highlighted the advanced technology behind RightDose, adding, "Matching thousands of unique drug dose and indication combinations with the specific needs of different age brackets requires a sophisticated system. Our technology ensures that healthcare providers receive the most relevant and accurate dosing information, which is critical given the lack of a single comprehensive source for this data."With the introduction of RightDose, Arkstone continues to set the standard in infectious disease management by providing evidence-based information and innovative tools that empower healthcare providers to make informed treatment decisions. This new feature reaffirms Arkstone's commitment to improving patient care worldwide through continuous innovation and precision-guided medicine.
News
Latest Insights and Updates
Stay informed with our featured press releases.
Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients
The Arkstone platform has been used by doctors across the USA to diagnose and treat diseases in over 1 million patients, a major milestone reached in October 2025. The milestone underscores Arkstone’s leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding partnerships across the U.S. and around the world.
Arkstone Announces RightDose, a Groundbreaking Enhancement to Ensure Proper Antimicrobial Prescribing
This innovative feature addresses the complexities healthcare providers face when dosing for different age groups and accommodating reduced renal and hepatic function
Arkstone Medical Solutions Launches Breakthrough OneChoice Report for Microbiology Lab Results
Leading Provider of Laboratory Infectious Disease Reporting Expands Precision-Guided Treatment Recommendations to Cultures and Stains
Customer Testimonials
Arkstone's solutions have transformed our patient care.
"Clinically, Arkstone has significantly decreased my time until optimal treatment. Thanks for your help saving limbs!"
"Successful wound healing requires expertise in the management of bioburdens, biofilms, and microbes. Arkstone's advanced input and patient-specific recommendations have translated to superior results in wound healing and patient satisfaction. This has led to better outcomes, unparalleled medical decision making, and respect among medical professionals in the mid-south."
"Our providers are so happy we partnered with Arkstone as now they have in depth and actionable guidance with each lab result."
"The Arkstone Reports provide recommendations and infection control measures that have significantly improved the way we care for patients. It is truly a unique feature that will revamp our antimicrobial stewardship programs."
"Arkstone does a great job of identifying pathogens and resistance to certain antibiotics, and we love the fact that the reports use a score to rank treatments that doctors can consider. The Arkstone Report assists our physicians in making wise decisions for antibiotic use and patient care."
"When it comes to PCR, results can be complicated. Arkstone is a great clinical tool that can help physicians choose the right regimen for their patients."
"After following the Arkstone antibiotic treatment recommendation my patient's wound is healing, the small red area is gone, and the overall redness has decreased indicating the infection is gone."
Take the Next Step, Try OneChoice®
No more guesswork. No more lookup tools. No more inaccuracies and inconsistencies. No more stopping to ask for directions.
